35 Tolar P, Hanna J, Krueger P D, et al. The constant region of the membrane immunoglobulin mediates B cell-receptor clustering and signaling in response to membrane antigens. Immunity, 2009, 30: 44-55
[2]
36 Tolar P, Pierce S K. A conformation-induced oligomerization model for B cell receptor microclustering and signaling. Curr Top Microbiol Immunol, 2010, 340: 155-169
[3]
37 Yang J, Reth M. Oligomeric organization of the B-cell antigen receptor on resting cells. Nature, 2010, 467: 465-469
[4]
38 Duehren-von Minden M, Uebelhart R, Schneider D, et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature, 2012, 489: 309-312
[5]
39 Mattila P K, Feest C, Depoil D, et al. The actin and tetraspanin networks organize receptor nanoclusters to regulate B cell receptor-mediated signaling. Immunity, 2013, 38: 461-474
[6]
40 Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol, 2000, 1: 31-39
[7]
41 Dykstra M, Cherukuri A, Sohn H W, et al. Location is everything: lipid rafts and immune cell signaling. Annu Rev Immunol, 2003, 21: 457-481
[8]
42 Sohn H W, Tolar P, Pierce S K. Membrane heterogeneities in the formation of B cell receptor-Lyn kinase microclusters and the immune synapse. J Cell Biol, 2008, 182: 367-379
[9]
43 Natkanski E, Lee W Y, Mistry B, et al. B cells use mechanical energy to discriminate antigen affinities. Science, 2013, 340: 1587-1590
[10]
44 Wang X, Ha T. Defining single molecular forces required to activate integrin and notch signaling. Science, 2013, 340: 991-994
[11]
45 Liu W, Meckel T, Tolar P, et al. Antigen affinity discrimination is an intrinsic function of the B cell receptor. J Exp Med, 2010, 207: 1095-1111
[12]
46 Treanor B, Depoil D, Bruckbauer A, et al. Dynamic cortical actin remodeling by ERM proteins controls BCR microcluster organization and integrity. J Exp Med, 2011, 208: 1055-1068
[13]
47 Monks C R, Freiberg B A, Kupfer H, et al. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature, 1998, 395: 82-86
[14]
48 Batista F D, Iber D, Neuberger M S. B cells acquire antigen from target cells after synapse formation. Nature, 2001, 411: 489-494
[15]
49 Fleire S J, Goldman J P, Carrasco Y R, et al. B cell ligand discrimination through a spreading and contraction response. Science, 2006, 312: 738-741
[16]
50 Schnyder T, Castello A, Feest C, et al. B cell receptor-mediated antigen gathering requires ubiquitin ligase Cbl and adaptors Grb2 and Dok-3 to recruit dynein to the signaling microcluster. Immunity, 2011, 34: 905-918
[17]
51 Hashimoto-Tane A, Yokosuka T, Sakata-Sogawa K, et al. Dynein-driven transport of T cell receptor microclusters regulates immune synapse formation and T cell activation. Immunity, 2011, 34: 919-931
[18]
52 Ilani T, Vasiliver-Shamis G, Vardhana S, et al. T cell antigen receptor signaling and immunological synapse stability require myosin IIA. Nat Immunol, 2009, 10: 531-539
[19]
53 Carrasco Y R, Fleire S J, Cameron T, et al. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity, 2004, 20: 589-599
[20]
70 Clatworthy M R, Willcocks L, Urban B, et al. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci USA, 2007, 104: 7169-7174
[21]
71 Kyogoku C, Dijstelbloem H M, Tsuchiya N, et al. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum, 2002, 46: 1242-1254
[22]
72 Pan F, Zhang K, Li X, et al. Association of Fcgamma receptor IIB gene polymorphism with genetic susceptibility to systemic lupus erythematosus in Chinese populations--a family-based association study. J Dermatol Sci, 2006, 43: 35-41
[23]
73 Chu Z T, Tsuchiya N, Kyogoku C, et al. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens, 2004, 63: 21-27
[24]
74 Siriboonrit U, Tsuchiya N, Sirikong M, et al. Association of Fcgamma receptor IIb and IIIb polymorphisms with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens, 2003, 61: 374-383
[25]
75 Chen JY, Wang C M, Wu J M, et al. Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis. Clin Exp Immunol, 2006, 144: 10-16
[26]
76 Kyogoku C, Tsuchiya N, Wu H, et al. Association of Fcgamma receptor IIA, but not IIB and IIIA, polymorphisms with systemic lupus erythematosus: a family-based association study in Caucasians. Arthritis Rheum, 2004, 50: 671-673
[27]
77 Liu W, Won Sohn H, Tolar P, et al. Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition. J Immunol, 2010, 184: 1977-1989
[28]
78 Xu L, Li G, Wang J, et al. Through an ITIM-independent mechanism the fcgammaRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19. J Immunol, 2014, 192: 5179-5191
[29]
79 Alizadeh A A, Eisen M B, Davis R E, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 2000, 403: 503-511
[30]
80 Davis R E, Brown K D, Siebenlist U, et al. Constitutive nuclear factor kappa B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med, 2001, 194: 1861-1874
[31]
81 Staudt LM. Oncogenic activation of NF-kB. Cold Spring Harb Perspect Biol, 2010, 2: a000109
[32]
82 Ngo V N, Davis R E, Lamy L, et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature, 2006, 441: 106-110
[33]
83 Lenz G, Davis R E, Ngo V N, et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science, 2008, 319: 1676-1679
[34]
17 He B, Chadburn A, Jou E, et al. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol, 2004, 172: 3268-3279
[35]
18 Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol, 2005, 5: 435-445
[36]
19 Mecklenbrauker I, Kalled S L, Leitges M, et al. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling. Nature, 2004, 431: 456-461
[37]
20 Gerondakis S, Strasser A. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin Immunol, 2003, 15: 159-166
[38]
21 Schweighoffer E, Vanes L, Nys J, et al. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity, 2013, 38: 475-488
[39]
22 Pierce S K, Liu W. The tipping points in the initiation of B cell signalling: how small changes make big differences. Nat Rev Immunol, 2010, 10: 767-777
[40]
23 Flaswinkel H, Reth M. Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO J, 1994, 13: 83-89
[41]
24 Benschop R J, Aviszus K, Zhang X, et al. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity, 2001, 14: 33-43
[42]
25 Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol, 1999, 17: 555-592
[43]
26 Rowley R B, Burkhardt A L, Chao H G, et al. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation. J Biol Chem, 1995, 270: 11590-11594
[44]
27 Wang Y, Brooks S R, Li X, et al. The physiologic role of CD19 cytoplasmic tyrosines. Immunity, 2002, 17: 501-514
[45]
28 Justement L B. The role of the protein tyrosine phosphatase CD45 in regulation of B lymphocyte activation. Int Rev Immunol, 2001, 20: 713-738
[46]
29 Saito K, Scharenberg A M, Kinet J P. Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J Biol Chem, 2001, 276: 16201-16206
[47]
30 Kang S W, Wahl M I, Chu J, et al. PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J, 2001, 20: 5692-5702
[48]
31 Aiba Y, Oh-hora M, Kiyonaka S, et al. Activation of RasGRP3 by phosphorylation of Thr-133 is required for B cell receptor-mediated Ras activation. Proc Natl Acad Sci USA, 2004, 101: 16612-16617
[49]
32 Chiu C W, Dalton M, Ishiai M, et al. BLNK: molecular scaffolding through ‘cis''-mediated organization of signaling proteins. EMBO J, 2002, 21: 6461-6472
[50]
33 D''Ambrosio D, Hippen K L, Cambier J C. Distinct mechanisms mediate SHC association with the activated and resting B cell antigen receptor. Eur J Immunol, 1996, 26: 1960-1965
[51]
34 Metzger H. Transmembrane signaling: the joy of aggregation. J Immunol, 1992, 149: 1477-1487
[52]
1 Harwood N E, Batista F D. Early events in B cell activation. Annu Rev Immunol, 2010, 28: 185-210
[53]
2 Kurosaki T, Aiba Y, Kometani K, et al. Unique properties of memory B cells of different isotypes. Immunol Rev, 2010, 237: 104-116
[54]
3 Reth M, Wienands J. Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol, 1997, 15: 453-479
[55]
4 Tolar P, Sohn H W, Pierce S K. The initiation of antigen-induced B cell antigen receptor signaling viewed in living cells by fluorescence resonance energy transfer. Nat Immunol, 2005, 6: 1168-1176
[56]
5 DeFranco A L. The complexity of signaling pathways activated by the BCR. Curr Opin Immunol, 1997, 9: 296-308
[57]
6 Dal Porto J M, Gauld S B, Merrell K T, et al. B cell antigen receptor signaling 101. Mol Immunol, 2004, 41: 599-613
[58]
7 Smith S H, Haas K M, Poe J C, et al. B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol, 2010, 22: 681-691
[59]
8 Lam K P, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell, 1997, 90: 1073-1083
[60]
9 Kraus M, Alimzhanov M B, Rajewsky N, et al. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell, 2004, 117: 787-800
[61]
10 Srinivasan L, Sasaki Y, Calado DP , et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell, 2009, 139: 573-586
[62]
11 Delgado P, Cubelos B, Calleja E, et al. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol, 2009, 10: 880-888
[63]
12 Ng L G, Mackay C R, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol, 2005, 42: 763-772
[64]
13 Schneider P, Tschopp J. BAFF and the regulation of B cell survival. Immunol Lett, 2003, 88: 57-62
[65]
14 Do RKG, Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev, 2002, 13: 19-25
[66]
15 Rolink A G, Melchers F. BAFF led B cells survive and thrive: roles of BAFF in B-cell development. Curr Opin Immunol, 2002, 14: 266-275
[67]
16 Melchers F. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann Rheum Dis, 2003, 62: ii25-ii27
[68]
54 Yokosuka T, Sakata-Sogawa K, Kobayashi W, et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol, 2005, 6: 1253-1262
[69]
55 Varma R, Campi G, Yokosuka T, et al. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity, 2006, 25: 117-127
[70]
56 Cemerski S, Das J, Giurisato E, et al. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. Immunity, 2008, 29: 414-422
[71]
57 Ramsay A G, Johnson A J, Lee A M, et al. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J Clin Invest, 2008, 118: 2427-2437
[72]
58 Schubert D A, Gordo S, Sabatino J J Jr, et al. Self-reactive human CD4 T cell clones form unusual immunological synapses. J Exp Med, 2012, 209: 335-352
[73]
59 Shih T A, Meffre E, Roederer M, et al. Role of BCR affinity in T cell dependent antibody responses in vivo. Nat Immunol, 2002, 3: 570-575
[74]
60 Paus D, Phan T G, Chan T D, et al. Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. The Journal of experimental medicine, 2006, 203: 1081-1091
[75]
61 Martin S W, Goodnow C C. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol, 2002, 3: 182-188
[76]
62 Horikawa K, Martin S W, Pogue S L, et al. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors. J Exp Med, 2007, 204: 759-769
[77]
63 Liu W, Meckel T, Tolar P, et al. Intrinsic properties of immunoglobulin IgG1 isotype-switched B cell receptors promote microclustering and the initiation of signaling. Immunity, 2010, 32: 778-789
[78]
64 Liu W, Chen E, Zhao X W, et al. The scaffolding protein synapse-associated protein 97 is required for enhanced signaling through isotype-switched IgG memory B cell receptors. Sci Signal, 2012, 5: ra54
[79]
65 Engels N, Konig L M, Heemann C, et al. Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells. Nat Immunol, 2009, 10: 1018-1025
[80]
66 Floto R A, Clatworthy M R, Heilbronn K R, et al. Loss of function of a lupus-associated Fc gamma RIIb polymorphism through exclusion from lipid rafts. Nat Med, 2005, 11: 1056-1058
[81]
67 Niederer H A, Willcocks L C, Rayner T F, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet, 2010, 19: 3282-3294
[82]
68 Willcocks L C, Carr E J, Niederer H A, et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc Natl Acad Sci USA, 2010, 107: 7881-7885
[83]
69 Li X, Wu J, Carter R H, et al. A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum, 2003, 48: 3242-3252
[84]
84 Davis R E, Ngo V N, Lenz G, et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature, 2010, 463: 88-92
[85]
85 Ngo V N, Young R M, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature, 2011, 470: 115-119
[86]
86 Zhu D L, McCarthy H, Ottensmeier C H, et al. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood, 2002, 99: 2562-2568
[87]
87 Shaffer AL 3rd, Young R M, Staudt L M. Pathogenesis of human B cell lymphomas. Annu Rev Immunol, 2012, 30: 565-610
